MCM
AGN

Mason Capital Management’s Allergan plc AGN Stock Holding History

Mason Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-921,000
Closed -$163M – 17
2020
Q1 		$163M Buy
+921,000
New +$173M 51.88% 1

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Mason Capital Management's AGN Position: Q2 2020 in Review

Mason Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 921,000 shares — an estimated $163M sold.

Mason Capital Management first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $163M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mason Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mason Capital Management sold 921,000 Allergan plc shares in Q2 2020, an estimated $163M.
  • Mason Capital Management first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Mason Capital Management's Allergan plc position peaked at $163M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mason Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.